Correlation Between Scpharmaceuticals and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Scpharmaceuticals and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Fennec Pharmaceuticals.
Diversification Opportunities for Scpharmaceuticals and Fennec Pharmaceuticals
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Fennec is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Fennec Pharmaceuticals
Given the investment horizon of 90 days Scpharmaceuticals is expected to generate 1.11 times more return on investment than Fennec Pharmaceuticals. However, Scpharmaceuticals is 1.11 times more volatile than Fennec Pharmaceuticals. It trades about -0.02 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 534.00 in Scpharmaceuticals on August 29, 2024 and sell it today you would lose (174.00) from holding Scpharmaceuticals or give up 32.58% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Scpharmaceuticals |
| Fennec Pharmaceuticals |
Scpharmaceuticals and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Fennec Pharmaceuticals
The main advantage of trading using opposite Scpharmaceuticals and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Fennec Pharmaceuticals vs. Molecular Partners AG | Fennec Pharmaceuticals vs. MediciNova | Fennec Pharmaceuticals vs. Anebulo Pharmaceuticals | Fennec Pharmaceuticals vs. Champions Oncology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |